II. Mechanism

  1. Ketamine-like drug of abuse used for its dissociative effects
  2. Grey market, designer drug

III. Adverse Effects

  1. Marketed to have less Nausea and Vomiting than Ketamine
  2. Cerebellar effects (may be longer lasting)
    1. Nystagmus
    2. Truncal Ataxia (wide-based drunken gait)
    3. Difficulty performing Rapid Alternating Movements
    4. Shields (2012) Clin Toxicol 50(5): 438-40 [PubMed]

IV. Labs: Urine Drug Screen

  1. Assay for PCP will likely be positive

V. Management: Agitation

VI. References

  1. Nordt and Swadron in Majoewsky (2012) EM:Rap 12(11): 9
  2. Wood (2012) Eur J Clin Pharmacol 68(5):853-6 [PubMed]

Images: Related links to external sites (from Bing)

Related Studies (from Trip Database) Open in New Window